Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder

NCT05683249 is registered in ClinicalTrials.gov with Neurocentria, Inc. as lead sponsor.

NCT NCT05683249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05683249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder
Lead sponsor
Neurocentria, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
February 25, 2023
Completion date
January 17, 2024
Enrollment
223 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

adhd